As such, we validated our cytotoxicity assay and documented that overexpression of SERPINB9, a natural inhibitor of granzyme B, in melanoma target cells rendered them resistant to NK-92 cytotoxicity (Fig. 2B). This evidence concerns the gene GZMB and melanoma.